Proteostasis Therapeutics

About:

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Website: http://www.proteostasis.com/

Twitter/X: PTI_Biotech

Top Investors: F-Prime Capital, Cormorant Asset Management, New Enterprise Associates, Novartis Venture Fund, Rock Springs Capital

Description:

Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.